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Abstract
Introduction: We studied the possible correlation between age, testosterone deficiency, cavernosal fibrosis and
erectile dysfunction (ED).
Methods: 47 patients with ED were enrolled between September 2010 and October 2011. IIEF-EF score, NPTR test
using the Rigiscan method, total and free testosterone levels, and cavernosum biopsy were carried out on all
patients. Patients aged 65 or over were defined as Old Age (OA) while patients under 65 were defined Young age
(YA). The strength of the relationships found was estimated by Odds Ratio.
Results: 74% of patients with values of over 52% collagen fibers in the corpora cavernosa were found to have
organic ED. A significant difference was found in age, percentage of collagen fibers, testosterone levels between
patients with Positive Rigiscan (PR) and Negative Rigiscan (NR). Hypotestosteronaemia increased the risk of ED with
PR (OR: 21.4, 95% CI: 20.2-22.6) and in both young age patients (OR: 4.3, 95% CI: 2.4-6.2) and old age patients (OR:
15.5, 95% CI: 13.4-17.6). Moreover cavernosal fibrosis increased the risk of ED with PR in both young age patients
(OR: 8.2, 95% CI: 6.4-10.0 and old age patients (OR: 24.6, 95% CI: 20.8-28.4).
Conclusions: This study demonstrates a strong association among age, testosterone deficiency, cavernosal fibrosis
and ED with PR. Age, testosterone deficiency and cavernosal fibrosis are potentially correctable factors of
cavernosal fibrosis and organic ED. Further, prospective studies are needed to evaluate if testosterone treatment,
alone or in association with PDE5 inhibitors, may lower the risk of cavernosal fibrosis or decrease the severity the
fibrosis in ED patients.
Background
Male ageing causes alterations in both libido and erectile
function. Although the majority of men over fifty are
still interested in sex, the prevalence of sexual activity
declines with age: 73% of patients who are 57 to 64
years of age are able to have regular sexual relations
(53% of patients who are 65-74 years of age and only
26% of patients who are 75 to 85 years of age) [1]. One
of the major causative factors of this is the elevated
incidence of Erectile Dysfunction (ED) that occurs in
the sixth and seventh decade of life. Erection is a com-
plex phenomenon involving the interaction of the auto-
nomic nervous system, cardiovascular system and local
neurotransmitters. Sexual stimulus brings about blood
flow into the corpus cavernosum and the consequent
penile rigidity is maintained by means of a veno-occlu-
sive mechanism. This is enabled by the particular micro-
architecture of the corpus cavernosum which consents a
sophisticated haemodynamic mechanism.
Androgens are essential for the development, growth
and maturation of the erectile tissues. In the animal model
testosterone suppression lead to corpora cavernosum
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atrophy with concomitant structural alterations of the dor-
sal nerve of the penis, endothelial alterations, reduction of
the smooth muscle component and increase in the deposi-
tion of extracellular matrix and cavernosal fibrosis. Andro-
gens, acting on the haemostasis in the corpora cavernosa,
regulate the growth of smooth muscle and protein synth-
esis of the connective tissue of the corpora cavernosa and
a decrease in their production could give rise to the switch
from elastic fibers to collagen fibers, which is the basis of
cavernosal fibrosis [2,3]. In the brain, low testosterone
levels are associated with a reduction in erectile signaling.
Studies in hypogonadal patients have shown that testoster-
one replacement results in significant increase in brain
activity in response to sexual stimulation, to levels similar
to those seen in men with normal testosterone. Recent
experimental evidence showed that Testosterone also reg-
ulates the expression of phosphodiesterasis type 5 (PDE5)
[4]. As age advances the gonadal steroid hormones and, in
particular, testosterone production decreases [5], nerve
conduction slows and the efficiency of the vascular micro-
circulation of the penis is reduced.
Furthermore it has been previously shown that as age
advances the collagen/elastic fibers ratio in the corpora
cavernosa increases [6]. Therefore, it seems that the
aging and the testosterone production decrease can lead
to a progressive fibrotic process of the corpora caver-
nosa which is related to testosterone.
However, to date it is still not clear what degree of
fibrosis gives rise to erectile dysfunctions in man, nor the
role of testosterone in the pathogenesis of cavernosal
fibrosis has yet been clarified. This study seeks to evalu-
ate the functional and microstructural alterations that
take place in the cavernosa tissue in a group of over fifty
ED patients with and without hypotestosteronaemia, in
order to establish the correlation and causal relationship
among age, testosterone deficiency and cavernosal fibro-
sis in men affected with ED.
Materials and methods
The study consisted in a descriptive investigation con-
duced from September 2010 and October 2011. Inclusion
criteria were: over fifty years of age, male patients with
stable marital relations and affected by Erectile Dysfunc-
tion (ED). Exclusion criteria were: diabetes mellitus and
other metabolic disorders (Impaired Glucose Tolerance,
Impaired Fasting Glucose, Metabolic Syndrome and con-
genital or acquired dyslipidemia), obesity, alcoholism,
smoking, hypertension, cardiovascular disease, Neurogenic
syndrome (Multiple sclerosis, Multiple atrophy, Parkin-
son’s disease, Tumors, Stroke, Disk disease, Spinal cord
disorders, Polyneuropathy, Uraemia), Peyronie’s disease,
Penile fracture, Congenital curvature of penis, Micropenis,
Hypospadias, Epispadias, Hyperprolattinemia, Hyper- and
Hypothyroidism, Cushing’s disease, drug assumption
(antihypertensives, antidepressants, antipsychotics, antian-
drogens, antihistamines, heroin, cocaine and methadone),
radiotherapy (pelvis or retroperitoneum) and lower pelvic
surgery (oncological pelvic surgery, lower urinary and gen-
ital tract surgery). We enrolled 47 patients presenting at
the Andrology Department of our Clinic. At visit patients
were evaluated by means of detailed medical and sexual
history, clinical examination, laboratory investigations
(Total and Free Testosterone), strumental examination
(NPTR with Rigiscan) and biopsies of the corpora caver-
nosa. The study was performed in compliance with the
guidelines of our institutional ethics committee.
Written informed consent was obtained from all
patients.
Patients aged 65 or over were defined as Old Age (OA)
while patients under 65 were defined Young age (YA).
We asked all patients to complete the International
Index of Erectile Function (IIEF) questionnaire: the IIEF
domain were calculated and ED grading was determined:
absent of ED (IIEF score 26 to 30), mild ED (IIEF score
17 to 25), moderate ED (EF score 11 to 16) and severe
ED (IIEF score < 10) [7].
All patients underwent nocturnal penile tumescence
and rigidity test (NPTR) with Rigiscan for three consecu-
tive nights. Normal erectile function was defined with the
recording of at least one erection (70 out of 100% tip
rigidity lasting for at least 10 min during either night) [8]:
we considered Negative Rigiscan (NR) patients who had
an erectile event of at least 70% rigidity recorded on the
tip of the penis, which lasted for 10 minutes or more, and
Positive Rigiscan (PR) remaining patients (Table 1). We
practiced this test with the intent of differentiating
organic and psychogenic erectile dysfunction [9]. Serum
testosterone concentrations were measured using the
DPC Coat-A-Count RIA kit, which has an intra- and
interassay coefficient of variation (CV) of < 10% while sex
hormone-binding globulin (SHBG) were measured by
ELISA technique (DRG Diagnostics, Marburg, Germany).
We calculated the measurement of free testosterone (FT)
from measured total testosterone (tT) and SHBG. These
measurement were obtained between 07.00 am and 11.00
am. There are no accepted lower limits of normal and it
is unclear whether geographically different threshold
depend on ethnic differences or on the physician’s per-
ception. However there is general agreement that total
testosterone levels above 12 nmol/L (346 ng/dL) or free
testosterone levels above 250 pmol/L (72 pg/mL) do not
require testosterone substitution. Similarly, testosterone
supplementation should be started according to the refer-
ence levels given in the recommendations of the ISA-
ISSAM-EAU [10] when serum total testosterone levels
are below 8 nmol/L (231 ng/dL) or free testosterone
levels are below 180 pmol/L (52 pg/mL) and when serum
total testosterone levels are between 12 and 8 nmol/L or
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free testosterone levels are between 250 and 180 pmol/L
in patients with symptoms of testosterone deficiency. So
we considered Normal Testosterone (NT) patients who
had total and testosterone levels above 12 nmol/L
(346 ng/dL) and free testosterone levels above 250 pmol/L
(72 pg/mL), and Low Testosterone (LT) patients who had
testosterone levels below 12 nmol/L (346 ng/dL) and free
testosterone levels below 250 pmol/L (72 pg/mL). Biopsies
of the corpora cavernosa were performed in all patients,
by means of an automatic needle, under local anesthesia
induced by 1cc of 5% carbocaine and an incision of 0.5 cm
at a distance of 1 cm from the balano-preputial groove
[11]. Connective tissue specimens were fixed in neutral
buffered 10% formalin for 12-24 hours, washed in ethanol,
processed by standard methods, embedded in paraffin,
sectioned at 4µm and stained with haematoxylin and
eosin, and with Masson’s Trichomome method by auto-
stainer. The connective tissue presents in specimens
stained with Masson’s Trichome method was evaluated by
computer image analysis (Eureka Interface System -
Menarini Diagnostic) with an analysis per area.
The study population was divided into two groups:
patients diagnosed with PR and patients NR, and com-
pared for mean age, percent collagen fibers content,
total and free testosterone levels by Student t test (p <
0.005). Moreover, further analysis were carried out in
both group YA and OA to quantify associations among
hypotestosteronaemia, cavernosal fibrosis and PR (95%
CI) in order to establish whether cavernosal fibrosis
and/or hypotestosteronaemia represent epiphenomena
of old age or the are factors involved in the onset of
organic ED.
Results and discussion
Forty-seven men, mean age 66 (+/- 3), were enrolled.
IIEF score, penile rigidometry, patients with PR, total and
free testosterone levels; number of patients diagnosed
with hypotestosteronaemia and percent of collagen fibers
cavernosal are reported (Table 1). When the whole group
was divided according to a positive or negative Rigiscan a
highly significant difference was found (p < 0.001) (Fig.1)
between age, degree of cavernosal fibrosis, and total and
free testosterone levels. As we can see in the group of
patients with PR there is the presence of a higher percen-
tage of collagen fibers, with a concomitant decrease of
smooth muscle cells. Furthermore there is a remarkable
difference of the serum free and total testosterone levels
between the PR (364 +/- 18 tT and 5.5 +/- 0.4 FT) and
NR groups (671 +/- 24 and 7.8 +/- 0.5) (Table 2).
A 2x2 chart was drawn up, taking the percent collagen
fibers content per area as an independent variable and
seeking to establish the most accurate fibrosis value (cut
off) to identify patients who had PR. This value was fixed
at 52%, that was reputed the best compromise between
higher sensitivity and specificity. So the subjects under
study were subdivided into two groups according to the
collagen fibers content present in the corpora cavernosa:
the first group, in which the collagen fibers at biopsy
were less than 52%, was denominated Low Fibrosis (LF),
and the second group, in which the collagen fibers at
biopsy were above 52%, was denominated High Fibrosis
(HF).
The strength of the relationships found among the
data was estimated by Odds Ratio, with 95% confidence
intervals (95% CI). Selecting a 52% cut off value of per-
centage of collagen fibers for cavernosal fibrosis we
obtained 74% sensitivity and 100% specificity to identify
patients who had NPTR test positive suggesting a diag-
nosis of organic ED. Thus a fibrosis > 52% is associated
with PR in 74% of cases (Table 3) whereas below this
value PR patients were not found. The strength of the
relationships found between hypotestosteronaemia/
cavernosal fibrosis and hypotestosteronaemia/Rigiscan’s
outcomes was estimated by Odds Ratio (Table 4).
Androgens play a crucial role in the maturation and dif-
ferentiation of erectile tissue. However, their role in the
erectile function of man is still on debate. In fact, in the
animal model, it has been shown that hypotestosteronae-
mia is responsible for corpora cavernosa atrophy, nervous
and endothelial structures modifications, smooth muscle
component decrease, collagen fibers neo-deposition, sub-
tunical adipocyte deposits and enzymatic inhibition of
nitric oxide synthases [5], while testosterone could play a
role in erectile signaling in the brain and on the other
hand could regulate the expression of PDE5 [3]. However,
androgen deficiency is “quite common” in men presenting
with ED, particularly if it is associated with uncontrolled
diabetes, high total cholesterol and anaemia [12]. This
study demonstrates that amongst patients affected with
mild to severe ED, the cavernosal fibrosis is greater in the
organic form than in the psychogenic form although we
know that NPTR has many advantages in differentiating
Table 1 Patients’ data
Age OA IIEF-EF Rigiscan Rigiscan Rigiscan (+) T tot T free LT Biopsy
Years old N (%) Average score Tip Base N° (%) ng/dl ng/dl N (%) % collagen fibers
66+/-3 26 (55) 13.5 +/- 4.3 50.4+/-2.5 50.5+/-2.7 35 (75) 443+/-22 6.1+/-0.3 20 (43) 53.5+/-2.7
Mean results of all the patients and all parameters investigated. 47 patients: Age, number (and %) of patients over 65, IIEF-EF score, Rigiscan test, number (and
%) of patients with PR, total and free testosterone, number (and %) of patients with hypotestosteronaemia, collagen fibers content per area present in corpora
cavernosa.
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psychogenic from organic ED, however, several questions
related to its physiological mechanisms do exist [13]. The
percentage of collagen fibers lower than 52% excludes an
organic component in the etiopathogenesis of ED, whereas
a content greater than 52% per area is associated to a 74%
of sensibility in the diagnosis of ED with Positive Rigiscan.
In patients who have undergone to radical prostatectomy,
the process of collagenization of the corpora cavernosa
takes place which could be associated with post-prosta-
tectomy ED [14]. However, it is clear that many other
etiologies such as vascular damage, smoking and metabolic
disorders can give rise to organic ED due to an increase in
cavernosal fibrosis [15]. To date the evaluation of caverno-
sal fibrosis has only been carried out by qualitative metho-
dology which does not estimate the degree of fibrosis
which is associated to organic erectile dysfunction. We
have also demonstrated that the degree of fibrosis is
directly correlated with age and inversely correlated with
total and free testosterone levels. The increase of caverno-
sal fibrosis with age has been previously reported by other
authors [16]. Furthermore the present study confirms the
association between age and cavernosal fibrosis by means
of the OR. In our opinion, the fact that fibrosis might be a
consequence of Hypotestosteronaemia, commonly found
in advanced age, is of great interest. An outcome very
interesting is that hypotestosteronaemia, cavernosal fibro-
sis and organic erectile dysfunction were rare in younger
patients but the presence of cavernosal fibrosis and/or
hypotestosteronaemia considerably increased the risk of
organic DE. This seems to confirm the strong association
among low testosterone levels, cavernosal fibrosis and
erectile dysfunction.
Conclusions
The aim of this study is to establish a connection
between the decrease of free and total testosterone levels
and the progressive cavernosal fibrosis, that plays a key
role in the etiology of ED. Androgens deficiency in the
aging male has become a topic of great interest and
debate due the increasing percentage of the population
belonging to the older age group. The data shows that
serum testosterone levels fall gradually with the age
(TDS) [17] with a concomitant increase of ED [18]. In
our study we have found that in the population of
patients affected by ED with a positive Rigiscan there are
low testosterone/free testosterone levels (364 ng/dL and
5.5 ng/dL) comparing to the group of patients with
Figure 1 ROC Curve. The area under the ROC curve is 0.91 (p<0.001). Confidence interval is 0.824 – 0.989.
Table 2 Student T test results on mean ages, percentage
of collagen fibres, free and total testosterone levels in
both the PR and NR. Results’ Student T in both
populations of patients: organic ED and psychogenic ED.
Positive Rigiscan Negative Rigiscan P
Age 70 56 .000 *
% Collagen Fibers 57.1 47.8 .000*
Total Testosterone 364 +/-18 671 +/-24 .000*
Free Testosterone 5.5 +/-0.4 7.8 +/-0.5 .000*
* significant difference between the means.
Table 3 Percent of collagen fibres in corpora cavernosa
in patients with PR and NR. Study group divided
according to the percentage collagen fibres revealed at
corpora cavernosa biopsy (a value >52% is considered
positive for high fibrosis) and Rigiscan’s results.
Positive Rigiscan Negative Rigiscan Total
HF 26 (55%) 0 (0%) 26 (55%)
LF 9 (20%) 12 (25%) 21 (45%)
Total 35 (75%) 12 (25%) 47(100%)
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negative Rigiscan and normal testosterone/free testoster-
one levels (Table 2). The correlation among androgens
decrease, cavernosal fibrosis and ED seems evident.
Therefore the ED associated to TDS (LOH) could be
linked to the testosterone decrease that characterizes this
syndrome and to the consequent cavernosal fibrosis, final
step toward the ED. The use of PDE5i have been used to
inhibit the cavernosal fibrosis resulting in patients under-
went radical prostatectomy [19,20]. Therefore the asso-
ciation of Testosterone replacement therapy and PDE5i
could be effective to contrast the cavernosal fibrosis
linked to the aging and to the testosterone decrease. The
same effect on the corpora cavernosa could be obtained
with the assumption of natural compounds containing
Protodioscin and Phlorotannins with antioxidant and
anti-fibrotic action [21,22].
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